Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Practice Management > More US Adults at High Risk for Vision Loss
  • Practice Management

More US Adults at High Risk for Vision Loss

Ophthalmology 360
More US Adults at High Risk for Vision Loss

Compared to 2002, adults in the United States were at a higher risk for vision loss in 2017, according to data published in JAMA Ophthalmol.

In this study, researchers examined data from the National Health Interview Survey from the years 2002 (n = 30,920) and 2017 (n = 32,886). Exclusion criteria included those under the age of 18 and people who were blind or unable to see. Age, sex, race/ethnicity, marital status, educational level, income-to-poverty ratio, health insurance status, diabetes diagnosis, vision or eye problems, and US region of residence were recorded.

Self-reported measures included visiting an eye care professional in the past 12 months, receiving a dilated eye examination in the past 12 months, and needing but being unable to afford eyeglasses in the past 12 months.

Participants who were 65 years or older, had diabetes, or vision/eye problems were considered to be at a high risk for vision loss.

Associations between measures and covariates examine with multivariable logistic regression models incorporating sampling weights. Temporal comparisons between 2002 and 2017 were derived from estimates standardized to the US 2010 census population.

The authors concluded that compared with 2002, more adults in the US were high risk for vision loss in 2017. Although there were improvements in the use of eye care services, a large number of Americans consider eyeglasses unaffordable.

“Focusing resources on populations at high risk for vision loss, increasing awareness of the importance of eye care, and making eyeglasses more affordable could promote eye health, preserve vision, and reduce disparities,” concluded the researchers.

Reference

Saydah SH, Gerzoff RB, Saaddine JB, et al. Eye care among US adults at high risk for vision loss in the United States in 2002 and 2017. JAMA Ophthalmol. Published online March 12, 2020. doi:10.1001/jamaophthalmol.2020.0273

Share

Related Content

  • Podcasts

Should you consider a pathway to clinical vision research?

37 Mins Listen
  • Practice Management

Global comparison shows significant differences in waste generated during eye surgery

  • Practice Management

ZEISS turns 100: the evolution of vision care, ophthalmology, and optical innovation

  • IOLs

Sustainability in ophthalmology: actionable tips

  • Practice Management

New review highlights urgent need to tackle adherence gaps in eye care throughout the patient life cycle

  • Trending Topics

Ophthalmic drugs account for a significant share of US drug shortages

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon